Works cited by this work

71 works

Work: Neurological Complications after COVID-19 Vaccination

1. Untitled

   Other8 citations

   ABIABI:AkademIndex/openalex/2026.other.232429

2. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

   Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26

   Article20208 citations

   ABIABI:AkademIndex/openalex/2026.other.373862

3. Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults

   Lianpan Dai, Lidong Gao, Lifeng Tao +27

   Article20227 citations

   ABIABI:AkademIndex/openalex/2026.other.232428

4. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

   Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +34

   Article20206 citations

   ABIABI:AkademIndex/openalex/2026.other.373863

5. Nervous system involvement after infection with COVID-19 and other coronaviruses

   Yeshun Wu, Xiaolin Xu, Zijun Chen +5

   Review article20205 citations

   ABIABI:AkademIndex/openalex/2026.other.310381

6. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

   Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov +28

   Article20215 citations

   ABIABI:AkademIndex/openalex/2026.other.554498

7. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

   Jerald Sadoff, Glenda Gray, An Vandebosch +27

   Article20214 citations

   ABIABI:AkademIndex/openalex/2026.other.555347

8. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

   Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael +30

   Article20203 citations

   ABIABI:AkademIndex/openalex/2026.other.373856

9. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

   Edward E. Walsh, Robert W. Frenck, Ann R. Falsey +22

   Article20203 citations

   ABIABI:AkademIndex/openalex/2026.other.373858

10. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

    Tom T. Shimabukuro, Michael Nguyen, David Martin +1

    Review article20153 citations

    ABIABI:AkademIndex/openalex/2026.other.571270

11. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes

    Dimitrios Karussis, Panayiota Petrou

    Review article20133 citations

    ABIABI:AkademIndex/openalex/2026.other.571313

12. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

    Cristina Menni, Kerstin Kläser, Anna May +25

    Article20213 citations

    ABIABI:AkademIndex/openalex/2026.other.571454

13. Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases

    Maxime Taquet, Masud Husain, John Geddes +2

    Article20213 citations

    ABIABI:AkademIndex/openalex/2026.other.717239

14. Improvements in Gene Therapy

    Thomas Ritter, Manfred Lehmann, Hans‐Dieter Volk

    Review article20022 citations

    ABIABI:AkademIndex/openalex/2026.other.717205

15. Intravascular adenoviral agents in cancer patients: Lessons from clinical trials

    Tony Reid, Robert S. Warren, David H. Kirn

    Review article20022 citations

    ABIABI:AkademIndex/openalex/2026.other.717206

16. Quadrivalent HPV Vaccination and Risk of Multiple Sclerosis and Other Demyelinating Diseases of the Central Nervous System

    Nikolai Madrid Scheller, Henrik Svanström, Björn Pasternak +4

    Article20152 citations

    ABIABI:AkademIndex/openalex/2026.other.717207

17. A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses

    Elizabeth S. Gabitzsch, Younong Xu, Lois H. Yoshida +4

    Article20082 citations

    ABIABI:AkademIndex/openalex/2026.other.717208

18. The influence of innate and pre‐existing immunity on adenovirus therapy

    Anne K. Zaiss, Hidevaldo B. Machado, Harvey R. Herschman

    Review article20092 citations

    ABIABI:AkademIndex/openalex/2026.other.717209

19. Epilepsy and vaccinations: Italian guidelines

    Dario Pruna, Paolo Balestri, Nelia Zamponi +8

    Review article20132 citations

    ABIABI:AkademIndex/openalex/2026.other.717210

20. Under-Reporting of Adverse Drug Reactions

    Lorna Hazell, Saad Shakir

    Review article20062 citations

    ABIABI:AkademIndex/openalex/2026.other.717211

21. Hemostasis factors and aging

    Daniela Mari, Raffaella Coppola, Rita Provenzano

    Review article20072 citations

    ABIABI:AkademIndex/openalex/2026.other.717212

22. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans

    Claudio Franceschi, Miriam Capri, Daniela Monti +10

    Review article20062 citations

    ABIABI:AkademIndex/openalex/2026.other.717213

23. Liver Toxicities Typically Induced by First-Generation Adenoviral Vectors Can Be Reduced by Use of E1, E2b-Deleted Adenoviral Vectors

    Ruth Everett, Bradley L. Hodges, Enyu Ding +3

    Article20032 citations

    ABIABI:AkademIndex/openalex/2026.other.717214

24. Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin

    Katalin Karikó, Hiromi Muramatsu, Jason M. Keller +1

    Article20122 citations

    ABIABI:AkademIndex/openalex/2026.other.717215

25. Live virus vaccines based on a yellow fever vaccine backbone: Standardized template with key considerations for a risk/benefit assessment

    Thomas P. Monath, Stephen Seligman, James S. Robertson +7

    Review article20142 citations

    ABIABI:AkademIndex/openalex/2026.other.717216